Christine E. Gray-Smith
Plus aucun poste en cours
Profil
Christine E.
Gray-Smith has been Chief Financial Officer and Senior Vice President of Anacor Pharmaceuticals, Inc since June, 2007.
She was Executive Vice President and Chief Financial Officer of CoTherix from April, 2004 to January, 2007.
Ms. Gray-Smith was Chief Financial Officer of Triad Therapeutics, Inc. from June, 2001 to April, 2004.
Before Triad, she served as Senior Financial Officer at Calydon and SUGEN, Inc. She held various positions at Arthur Young & Co. Ms. Gray-Smith received a BA degree from the University of California, Berkeley and an MBA from the Haas School of Business at the University of California, Berkeley.
Anciens postes connus de Christine E. Gray-Smith
| Sociétés | Poste | Fin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur Financier/CFO | 01/04/2009 |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Directeur Financier/CFO | 18/07/2007 |
Triad Therapeutics, Inc.
 Triad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA. | Directeur Financier/CFO | 01/04/2004 |
| Arthur Young & Co. | Corporate Officer/Principal | - |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Directeur Financier/CFO | - |
Formation de Christine E. Gray-Smith
| University of California, Berkeley | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Calydon, Inc.
 Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Health Technology |
Triad Therapeutics, Inc.
Triad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Arthur Young & Co. | Commercial Services |